Phase 4 Pharmacovigilance Trial of Paromomycin Injection for the Treatment of Visceral Leishmaniasis in India
Background. A phase 3 study demonstrated the safety and efficacy of paromomycin (paromomycin IM injection) for treatment of VL in an inpatient setting. Methods. This phase 4 study was conducted to assess the safety and efficacy of paromomycin in children and adults in an outpatient setting in Bihar,...
Saved in:
Main Authors: | Prabhat K. Sinha, T. K. Jha, Chandreshwar P. Thakur, Devendra Nath, Supriyo Mukherjee, Amrendra Kumar Aditya, Shyam Sundar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Journal of Tropical Medicine |
Online Access: | http://dx.doi.org/10.1155/2011/645203 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Safety of Paromomycin for Visceral Leishmaniasis: A Systematic Review
by: Pashupati Pokharel, et al.
Published: (2021-01-01) -
Association of Interleukin-18 Gene Polymorphism with Susceptibility to Visceral Leishmaniasis in Endemic Area of Bihar, an Indian Population
by: Dinesh Kumar, et al.
Published: (2014-01-01) -
Immunity to Visceral Leishmaniasis
by: Nahid Ali, et al.
Published: (2012-01-01) -
Visceral Leishmaniasis Clinical Management in Endemic Districts of India, Nepal, and Bangladesh
by: Megha Raj Banjara, et al.
Published: (2012-01-01) -
Visceral Leishmaniasis or Systemic Lupus Erythematosus Flare?
by: Sunny Garg, et al.
Published: (2012-01-01)